Methylprednisolone in combination with interferon beta-1a for relapsing-remitting multiple sclerosis (MECOMBIN study): a multicentre, double-blind, randomised, placebo-controlled, parallel-group trial : The Lancet Neurology
Links shared publicly online about this topic.
- 1,109total visits
Methylprednisolone in combination with interferon beta-1a for relapsing-remitting multiple sclerosis (MECOMBIN study): a multicentre, double-blind, randomised, placebo-controlled, parallel-group trial : The Lancet Neurology
Methylprednisolone in combination with interferon beta-1a for relapsing-remitting multiple sclerosis (MECOMBIN study): a multicentre, double-blind, randomised, placebo-controlled, parallel-group tr...
View full resource at thelancet.com
Tags: Neurology, Multiple Sclerosis, Multiple Sclerosis Medication, Avonex, Rebif, Depo-Medrol, Medrol, Solu-Medrol
Most Recently Shared on June 8, 2010 at 5:44 pm By:
Methylprednisolone in combination with interferon beta-1a for relapsing-remitting multiple sclerosis (MECOMBIN stu... http://bit.ly/awrkry
Methylprednisolone in combination with interferon beta-1a for relapsing-remitting multiple sclerosis (MECOMBIN study): a multicentre, double-blind, randomised, placebo-controlled, parallel-group trial : The Lancet Neurology
thelancet.com — “Methylprednisolone in combination with interferon beta-1a for relapsing-remitting multiple sclerosis (MECOMBIN study): a multicentre, double-blind, randomised, placebo-controlled, parallel-group tr...” View full resource at thelancet.com
Most Recently Shared on June 8, 2010 at 1:03 pm By:
MECOMBIN study published in The Lancet Neurology http://bit.ly/axFJ6W
Advertisement
